Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shinpei TADA"'
Autor:
Kosuke Hamai MD, PhD, Ryo Katsura MD, Shinya Miyake MD, Suguru Fujita MD, Shinpei Tada MD, Tetsu Hirakawa MD, Sayaka Ueno MD, Takuya Tanimoto MD, PhD, Nobuhisa Ishikawa MD, PhD
Publikováno v:
Cancer Control, Vol 31 (2024)
Introduction Docetaxel plus ramucirumab (DTX + RAM) therapy is a standard treatment for previously treated lung cancer, but many adverse events have been reported. This retrospective study was conducted to examine if the side effects of DTX + RAM the
Externí odkaz:
https://doaj.org/article/d73842c03f88488690add78a116e86b0
Autor:
Kosuke Hamai, Shinya Miyaka, Shinpei Tada, Suguru Fujita, Tetsu Hirakawa, Mirai Matsumura, Sayaka Ueno, Takuya Tanimoto, Nobuhisa Ishikawa
Publikováno v:
Cancer Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
Abstract Background Pegfilgrastim is recommended in docetaxel plus ramucirumab (DTX + RAM) therapy for recurrent nonsmall cell lung cancer (NSCLC) because of the associated frequency of febrile neutropenia (FN). However, the FN occurs less frequently
Externí odkaz:
https://doaj.org/article/9bbb937f0fdb497bb48a3030a5bba9c7
Autor:
Yoshihiro Kitahara, Motoki Matsuura, Rie Yamasaki, Kanako Nakamoto, Shinji Kakumoto, Shinpei Tada, Noriaki Ito, Kei Miwata, Mafumi Okimoto, Toshiro Takafuta
Publikováno v:
Clinical Case Reports, Vol 11, Iss 2, Pp n/a-n/a (2023)
Abstract A 40‐year‐old man was admitted with a diagnosis of COVID‐19 pneumonia. Although most of multiple ground‐glass opacities and consolidations on computed tomography improved, a round ground‐glass opacity with consolidation remained un
Externí odkaz:
https://doaj.org/article/09475a233e334703a68e2308d43aa028
Autor:
Takuya Tanimoto, Mirai Matsumura, Shinpei Tada, Suguru Fujita, Sayaka Ueno, Kosuke Hamai, Takuji Omoto, Hiroyuki Maeda, Takashi Nishisaka, Nobuhisa Ishikawa
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 534-535 (2021)
Externí odkaz:
https://doaj.org/article/87983dde008f4688856b83a9483fb434
Autor:
Yui TAKAHARA, Masaya MORIWAKI, Maiko TANAKA, Shinpei TADA, Kousuke HAMAI, Nobuhisa ISHIKAWA, Maya KOTACHI
Publikováno v:
Nishi Nihon Hifuka. 84:308-311
Autor:
Takuya Tanimoto, Shinpei Tada, Suguru Fujita, Tetsu Hirakawa, Mirai Matsumura, Shoko Isoyama, Sayaka Ueno, Kosuke Hamai, Naoki Tsuji, Hideyasu Hirosawa, Tomohiro Taniguchi, Takeshi Okamoto, Takuji Omoto, Shinji Kusunoki, Hiroyuki Maeda, Nobuhisa Ishikawa
Publikováno v:
Respiratory Investigation. 60:418-424
In this retrospective cohort study, we evaluated the efficacy of baricitinib in the treatment of coronavirus disease 2019 (COVID-19). Among 404 adult patients with COVID-19 who were admitted to our hospital between October 23, 2020, and July 31, 2021
Autor:
Suguru Fujita, Kosuke Hamai, Shinpei Tada, Mirai Matsumura, Sayaka Ueno, Takuya Tanimoto, Nobuhisa Ishikawa
Publikováno v:
Haigan. 62:33-37
Autor:
Kosuke Hamai, Ryo Katsura, Shinya Miyake, Suguru Fujita, Shinpei Tada, Tetsu Hirakawa, Sayaka Ueno, Takuya Tanimoto, Nobuhisa Ishikawa
Purpose Docetaxel plus ramucirumab (DTX + RAM) therapy is a standard treatment for previously treated lung cancer, but many adverse events has been reported. Therefore, this retrospective study was conducted to examine if the side effects of DTX + RA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7ad6612f012c5c6fa5132784bf22c84
https://doi.org/10.21203/rs.3.rs-2009580/v2
https://doi.org/10.21203/rs.3.rs-2009580/v2
Autor:
Sayaka Ueno, Takashi Nishisaka, Takuji Omoto, Takuya Tanimoto, Mirai Matsumura, Shinpei Tada, Kosuke Hamai, Hiroyuki Maeda, Suguru Fujita, Nobuhisa Ishikawa
Publikováno v:
Journal of Microbiology, Immunology and Infection
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 534-535 (2021)
Journal of Microbiology, Immunology, and Infection
Journal of Microbiology, Immunology and Infection, Vol 54, Iss 3, Pp 534-535 (2021)
Journal of Microbiology, Immunology, and Infection
We report a case of false-positive results for SARS-CoV-2-specific antigen. A patient initially had positive results on immunochromatographic SARS-CoV-2-specific antigen test, followed by negative results on RT-PCR assay of saliva and SARS-CoV-2-spec
Autor:
Hiroshi Tanaka, Shinpei Tada, Hiroyasu Yamamoto, Isao Ikemoto, Keiko Ohi, Yoshindo Kawaguchi, Osamu Sakai, Yukihiko Ohishi, Takashi Shigematsu
Publikováno v:
Nihon Toseki Igakkai Zasshi. 30:141-145
後天性多嚢胞腎 (acquired cystic desease of the kidneys, ACDK) に腎細胞癌 (renal cell carcinoma, RCC) を合併し, 血中エリスロポエチン (erythropoietin, EPO) 濃度が腫瘍マーカーとして有用であった透析患者の1